STAT+: RevMed’s pancreatic cancer drug nears European approval

STAT News·October 16, 2026 at 1:38 PM

statnews.com

Following a green light from the FDA, European regulators have now recommended the approval of Revolution Medicines' Rasonque for pancreatic cancer.

Chat about this story

Quick actions

STAT News2 days ago

Last updated 1 day ago

17°

Isolated showers

High 17°

Low 5°

Sat

17°

5°

Sun

15°

2°

Mon

17°

5°

Tue

19°

12°

Wed

17°

10°

Last updated 1 day ago

8,908.43+0.78%